Diagnostic Imaging Members: Login | Register

Diagnostic Imaging
    About Us

TOPIC CENTERS


MORE INFO



Home » Conference Reports » RSNA 2008 » Nuclear Imaging

DiagnosticImaging.com.
 

GE introduces new PET/CT

By Greg Freiherr | December 5, 2008

Discovery PET/CT 600 debuted at the RSNA meeting, taking a midtier position in GE Healthcare’s family of hybrid devices. Discovery PET/CT 600 uses an infrared tracking camera and reflective marker to measure a patient’s respiratory pattern and range of motion that can complicate imaging and lead to problems in evaluating patients for radiation therapy. The real-time position-management technology, developed by Varian Medical Systems, was integrated into the GE device through a partnership between the two firms. Synchronizing the scan with respiration requires substantial processing power, according to GE. The company met the challenge through a collaboration with IBM, which provided its BladeCenter server technology for use in the PET/CT.

 

 

Join the Conversation

Want to join the conversation? Just sign in or register today to become part of our growing, online community.





RSNA 2008 Nuclear Imaging

GE introduces new PET/CT
December 5, 2008

Discovery PET/CT 600 debuted at the RSNA meeting, taking a midtier position in GE Healthcare’s family of hybrid devices.

Researchers find low-dose PET/CT best imaging method for lymphoma
December 4, 2008

Low-dose PET/CT demonstrates the best sensitivity and specificity for initial staging of lymphoma, according to a study presented on Thursday at the RSNA meeting.

Gamma imaging picks up cancer unseen by mammograms
December 3, 2008

Out of every 10 women whose mammogram or physical exam reveals potentially cancerous cells in their breasts, approximately three of them will have additional dangerous clusters the examinations missed, according to a recent study presented at the RSNA conference Wednesday.

PET/CT in prostate cancer influences staging, treatment strategy
November 30, 2008

Prostate-specific antigen measurements are considered a useful organ-specific marker, but they are not necessarily an adequate tumor marker. PET/CT in combination with PSA levels can play a significant role in detecting and staging prostate cancer, according to two presentations Sunday at RSNA 2008.

RSNA preview: Cancer specialists voice mixed feelings about oncology imaging
November 20, 2008

RSNA presentations on prostate cancer staging and treatment, along with talks on radiation therapy for thoracic malignancies, have piqued the interest of cancer care specialists. But in general, oncologists and radiation oncologists conveyed some reservations about this year’s offerings in oncologic imaging and therapies.






CancerNetwork | CME LLC | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2012 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy